[HTML][HTML] Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: results of the GASTric cancer HER2 reassessment study 3 …
S Seo, MH Ryu, YS Park, JY Ahn, Y Park, SR Park… - Gastric Cancer, 2019 - Springer
Background Although discordance in HER2 positivity between primary and metastatic lesions
is well established, changes in HER2 positivity after anti-HER2 therapy have not been well …
is well established, changes in HER2 positivity after anti-HER2 therapy have not been well …
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer
Immune-related adverse events (irAEs) induced by checkpoint inhibitors involve a multitude
of different risk factors. Here, to interrogate the multifaceted underlying mechanisms, we …
of different risk factors. Here, to interrogate the multifaceted underlying mechanisms, we …
Optical gain at 1.54 μm in erbium-doped silicon nanocluster sensitized waveguide
HS Han, SY Seo, JH Shin - Applied physics letters, 2001 - pubs.aip.org
Optical gain at 1.54 μm in erbium-doped silicon-rich silicon oxide (SRSO) is demonstrated.
Er-doped SRSO thin film was fabricated by electron-cyclotron resonance enhanced chemical …
Er-doped SRSO thin film was fabricated by electron-cyclotron resonance enhanced chemical …
[HTML][HTML] Functional impairments in the mental health, depression and anxiety related to the viral epidemic, and disruption in healthcare service utilization among …
…, SH Kim, MJ Kwon, HJ Kim, SJ Koh, S Seo… - Cancer Research and …, 2022 - ncbi.nlm.nih.gov
Purpose Literature is scarce regarding cancer care utilization during the massive outbreak of
coronavirus disease 2019 (COVID-19) in the Republic of Korea. We investigated functional …
coronavirus disease 2019 (COVID-19) in the Republic of Korea. We investigated functional …
[HTML][HTML] Blockade of CCL2 expression overcomes intrinsic PD-1/PD-L1 inhibitor-resistance in transglutaminase 2-induced PD-L1 positive triple negative breast cancer
…, S Yoon, HM Ryu, E Lee, Y Jo, S Seo… - American Journal of …, 2020 - ncbi.nlm.nih.gov
Anti-PD-1/PD-L1 immunotherapy, as a treatment for many tumors, has shown good efficacy.
However, responses to immunotherapy did not always occur or last long., ie primary or …
However, responses to immunotherapy did not always occur or last long., ie primary or …
[HTML][HTML] Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era
The prognostic value of serum beta-2 microglobulin for diffuse large B-cell lymphoma (DLBCL)
is not well known in the rituximab era. A retrospective registry data analysis of 833 …
is not well known in the rituximab era. A retrospective registry data analysis of 833 …
A phase 2 multicenter study of docetaxel‐PM and trastuzumab‐pkrb combination therapy in recurrent or metastatic salivary gland carcinomas
J Lee, S Park, HA Jung, SH Lee, S Seo, SB Kim… - Cancer, 2023 - Wiley Online Library
Background Salivary duct carcinoma (SDC) is uncommon but is the most aggressive subtype
of salivary gland carcinomas. The high positivity rate for human epidermal growth factor …
of salivary gland carcinomas. The high positivity rate for human epidermal growth factor …
[HTML][HTML] The GTP binding activity of transglutaminase 2 promotes bone metastasis of breast cancer cells by downregulating microRNA-205
S Seo, Y Moon, J Choi, S Yoon, KH Jung… - American Journal of …, 2019 - ncbi.nlm.nih.gov
Previous studies have shown that transglutaminase 2 (TG2) induces epithelial to mesenchymal
transition (EMT) in various tumors. Several studies have also demonstrated the critical …
transition (EMT) in various tumors. Several studies have also demonstrated the critical …
[HTML][HTML] Clinical features and outcomes in patients with human immunodeficiency virus-negative, multicentric Castleman's disease: a single medical center experience
S Seo, C Yoo, DH Yoon, S Kim, JS Park, CS Park… - Blood …, 2014 - ncbi.nlm.nih.gov
Background Multicentric Castleman's disease (CD) is commonly associated with poor prognosis,
and well-known prognostic factors are scarce. We performed a retrospective analysis to …
and well-known prognostic factors are scarce. We performed a retrospective analysis to …
Characteristics of metastatic brachial plexopathy in patients with breast cancer
…, SB Kim, KH Jung, JH Ahn, JE Kim, S Seo - Supportive Care in …, 2020 - Springer
Purpose Brachial plexopathy in cancer patients is a rare but significant complication that
causes pain and disability of the upper extremities. Clinical features of breast cancer patients …
causes pain and disability of the upper extremities. Clinical features of breast cancer patients …